Atorvastatin for the Treatment of Retinal Vein Occlusion

Inclusion Criteria: * Adults aged 40 years and older * Diagnosed with CRVO or BRVO * Visual acuity of 20/40 or worse in the affected eye * Onset of current symptoms of loss of vision within the past 60 days * Ability to understand spoken English Exclusion Criteria: * Current use of a statin or fibrate medication * Known cardiovascular disease or revascularization, including coronary artery disease (myocardial infarction or angina), stroke or peripheral artery occlusion * Known diabetes mellitus * Known liver disease * Serum low-density lipoprotein cholesterol (LDL-C) \> 5.0 mmol/L * Baseline serum triglycerides \> 6.0 mmol/L * Serum ALT above 115 U/L (i.e., 2.5 x upper limit of normal) * Baseline serum creatinine \> 250 µmol/L * Ocular surgery within the past 90 days * Planned ocular or cataract surgery within the study period * Known retinal disease: age-related macular degeneration, retinal detachment or macular hole, or past history of vein occlusion * Women who are pregnant or who are breastfeeding * Participation in another clinical trial concurrently or within 30 days prior to screening * Known allergy to fluorescein dye * Current use of cyclosporine medication. * Current use of an HIV protease inhibitor medication.